Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.01 per share
-
Shares outstanding
-
221,930,814
-
Total 13F shares
-
12,858,041
-
Share change
-
+8,828,959
-
Total reported value
-
$59,779,684
-
Price per share
-
$4.65
-
Number of holders
-
20
-
Value change
-
+$41,047,156
-
Number of buys
-
15
Institutional Holders of Inventiva, S.A. - Ordinary Shares, nominal value EUR0.01 per share (IVA) as of Q4 2025
As of 31 Dec 2025,
Inventiva, S.A. - Ordinary Shares, nominal value EUR0.01 per share (IVA) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,858,041 shares.
The largest 10 holders included
SAMSARA BIOCAPITAL, LLC, Paradigm Biocapital Advisors LP, ADAR1 Capital Management, LLC, Trails Edge Capital Partners, LP, MILLENNIUM MANAGEMENT LLC, UBS Group AG, SymBiosis Capital Partners, LLC, FRANKLIN RESOURCES INC, Caligan Partners LP, and Polar Capital Holdings Plc.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.